NYSE:A - Agilent Technologies Stock Price, Forecast & News

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Agilent Technologies declared a quarterly dividend on Wednesday, November 20th. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.18 per share on Wednesday, January 22nd. This represents a $0.72 annualized dividend and a dividend yield of 0.80%. The ex-dividend date is Monday, December 30th. This is a positive change from Agilent Technologies's previous quarterly dividend of $0.16. View Agilent Technologies' Dividend History.

Agilent Technologies announced that its board has authorized a share repurchase program on Monday, November 19th 2018, which authorizes the company to buyback $1,750,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to repurchase up to 8.8% of its stock through open market purchases. Stock buyback programs are generally a sign that the company's management believes its shares are undervalued.

Agilent Technologies Inc (NYSE:A) released its earnings results on Monday, November, 25th. The medical research company reported $0.89 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.86 by $0.03. The medical research company had revenue of $1.37 billion for the quarter, compared to analysts' expectations of $1.33 billion. Agilent Technologies had a net margin of 20.74% and a return on equity of 20.13%. The business's revenue was up 5.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.81 EPS. View Agilent Technologies' Earnings History.

Agilent Technologies is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Agilent Technologies.

Agilent Technologies updated its FY20 earnings guidance on Monday, November, 25th. The company provided earnings per share (EPS) guidance of $3.38-3.43 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.44. The company issued revenue guidance of $5.50-5.55 billion, compared to the consensus revenue estimate of $5.55 billion.

13 equities research analysts have issued twelve-month price targets for Agilent Technologies' stock. Their forecasts range from $76.00 to $100.00. On average, they expect Agilent Technologies' stock price to reach $85.31 in the next twelve months. This suggests that the stock has a possible downside of 5.3%. View Analyst Price Targets for Agilent Technologies.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 5 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Agilent Technologies.

News articles about A stock have been trending somewhat positive recently, according to InfoTrie Sentiment. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Agilent Technologies earned a daily sentiment score of 0.7 on InfoTrie's scale. They also assigned media coverage about the medical research company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Agilent Technologies.

Agilent Technologies saw a drop in short interest during the month of December. As of December 31st, there was short interest totalling 4,660,000 shares, a drop of 9.2% from the December 15th total of 5,130,000 shares. Based on an average daily trading volume, of 1,570,000 shares, the short-interest ratio is presently 3.0 days. Currently, 1.5% of the company's stock are sold short. View Agilent Technologies' Current Options Chain.

Some companies that are related to Agilent Technologies include Thermo Fisher Scientific (TMO), Illumina (ILMN), Mettler-Toledo International (MTD), Waters (WAT), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), Bruker (BRKR), BIO-TECHNE (TECH), Charles River Laboratories Intl. (CRL), Cambrex (CBM), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO) and aTyr Pharma (LIFE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include AbbVie (ABBV), NVIDIA (NVDA), Alibaba Group (BABA), AT&T (T), Netflix (NFLX), Walt Disney (DIS), Boeing (BA), Paypal (PYPL), Intel (INTC) and Broadcom (AVGO).

Agilent Technologies' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include LGT Capital Partners LTD. (0.19%), Calamos Advisors LLC (0.16%), Hexavest Inc. (0.15%), Hahn Capital Management LLC (0.12%), Commerzbank Aktiengesellschaft FI (0.06%) and Artemis Investment Management LLP (0.05%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Dominique Grau, Heidi Fields, Mark Doak, Michael R Mcmullen, Michael Tang, Patrick G Hagan, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Institutional Ownership Trends for Agilent Technologies.

A stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Boston Trust Walden Corp, Hahn Capital Management LLC, Sciencast Management LP, Calamos Advisors LLC, Commerzbank Aktiengesellschaft FI and IFM Investors Pty Ltd. Company insiders that have sold Agilent Technologies company stock in the last year include Dominique Grau, Heidi Fields, Mark Doak, Michael R Mcmullen, Michael Tang, Paul N Clark and Rodney Gonsalves. View Insider Buying and Selling for Agilent Technologies.

A stock was acquired by a variety of institutional investors in the last quarter, including Hexavest Inc., Artemis Investment Management LLP, PGGM Investments, LGT Capital Partners LTD., Johanson Financial Advisors Inc., DNB Asset Management AS, AE Wealth Management LLC and Fruth Investment Management. View Insider Buying and Selling for Agilent Technologies.

Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of A stock can currently be purchased for approximately $90.12.

Agilent Technologies has a market capitalization of $27.95 billion and generates $5.16 billion in revenue each year. The medical research company earns $1.07 billion in net income (profit) each year or $3.11 on an earnings per share basis. Agilent Technologies employs 16,300 workers across the globe.View Additional Information About Agilent Technologies.

The official website for Agilent Technologies is http://www.agilent.com/.

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at 800-227-9770 or via email at [email protected]